View all IQVIA events
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREThe Potential Impact of COVID-19 on the MedTech Commercial Model
Financial objectives and market forces meant MedTech companies were already rethinking their traditional commercial models - then came COVID-19. It has changed the game for the MedTech industry by demonstrating the importance of MedTech manufacturers in healthcare and highlighting the need to accelerate commercial model changes.
As we work together to keep healthcare moving forward in spite of the current climate, it's important to lean on what we know. The ability to see healthcare professionals (HCPs) face-to-face has been greatly reduced, yet the need to communicate with HCPs and patients and provide them with relevant information is greater than ever.
What will happen if post-COVID-19, access is still only for those deemed "essential"? What does the future look like for field reps in the MedTech industry? How can we add value to HCP customers, keep business on track, and mitigate risk without the ability to see HCPs in-person?
MedTech companies around the world are asking these questions and are struggling to find the most effective way to manage their commercial teams in order to maintain critical relationships and deliver value.
This webinar brings together industry experts who will outline how MedTech companies are adapting their commercial models with multi-channel strategies to address the immediate COVID-19-related challenges as well as support longer-term commercial success.
Join this webinar to understand:
- COVID-19's immediate impact on the MedTech commercial market
- Examples of the changes MedTech companies are making so far
- Strategies for pivoting quickly and maintaining open lines of communication with HCPs without face-to-face interaction
- Best practices to equip Sales Reps for effective remote engagement
- Anticipated commercial model changes after COVID-19
Speakers
- Todd Schaefer - VP of Sales, IQVIA MedTech
- Liz Murray - Senior Director of Contract Sales and Medical Solutions, IQVIA MedTech
- Ann Mayer - Senior Principal, IQVIA MedTech
- Melissa Fischer - RN, MSN, CNOR, IQVIA Nurse Educator – Clinical Specialist, IQVIA MedTech
- Brad Hildreth - Senior Director, Business Development, IQVIA
- April Hollis - AdvaMed SmartBrief Editor, SmartBrief